Literature DB >> 20082924

Cardiovascular outcomes in randomized trials: should time to first event for "hard" end points remain the standard approach?

Steven E Nissen.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20082924     DOI： 10.1016/j.jacc.2009.09.021

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  7 in total

1.  Two Randomized Clinical Trials on the Treatment of Secondary Mitral Regurgitation-Contradictory or Complementary?

Authors:  Gilbert H L Tang; Subodh Verma; Deepak L Bhatt
Journal:  JAMA Cardiol       Date:  2019-04-01       Impact factor: 14.676

2.  Metabolic rates of ATP transfer through creatine kinase (CK Flux) predict clinical heart failure events and death.

Authors:  Paul A Bottomley; Gurusher S Panjrath; Shenghan Lai; Glenn A Hirsch; Katherine Wu; Samer S Najjar; Angela Steinberg; Gary Gerstenblith; Robert G Weiss
Journal:  Sci Transl Med       Date:  2013-12-11       Impact factor: 17.956

3.  Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial.

Authors:  Subodh Verma; Stephen C Bain; John B Buse; Thomas Idorn; Søren Rasmussen; David D Ørsted; Michael A Nauck
Journal:  JAMA Cardiol       Date:  2019-12-01       Impact factor: 14.676

4.  Depression treatment in patients with coronary artery disease: a systematic review.

Authors:  Gita Ramamurthy; Edgardo Trejo; Stephen V Faraone
Journal:  Prim Care Companion CNS Disord       Date:  2013-10-24

5.  Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial.

Authors:  R K Simmons; S J Sharp; A Sandbæk; K Borch-Johnsen; M J Davies; K Khunti; T Lauritzen; G E H M Rutten; M van den Donk; N J Wareham; S J Griffin
Journal:  Diabet Med       Date:  2012-11       Impact factor: 4.359

Review 6.  Cardiovascular risk scores do not account for the effect of treatment: a review.

Authors:  S M Liew; J Doust; P Glasziou
Journal:  Heart       Date:  2011-05       Impact factor: 5.994

7.  Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.

Authors:  Peter Gæde; Jens Oellgaard; Bendix Carstensen; Peter Rossing; Henrik Lund-Andersen; Hans-Henrik Parving; Oluf Pedersen
Journal:  Diabetologia       Date:  2016-08-16       Impact factor: 10.122
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.